CD14 and Miyoshi myopathy: In contrast, a previous study showed that patients treated with lenalidomide have high numbers of CD14+ CD15+ myeloid cells able to inhibit T-cell proliferation in vitro [11] At this moment, there is no consensus on the frequency and function of moMDSCs in MM patients.